Baronsmead Second Venture Trust Reports 7.1% NAV Decline Amid Market Volatility

Baronsmead VCT reports 7.1% NAV dip amid market volatility, highlighting resilient unquoted holdings while navigating AIM sector challenges. New investments continue.

Hide Me

Written By

Joshua
Reading time
» 4 minute read 🤓
Share this

Unlock exclusive content ✨

Just enter your email address below to get access to subscriber only content.
Join 104 others ⬇️
Written By
Joshua
READING TIME
» 4 minute read 🤓

Un-hide left column

Navigating the Headwinds: Baronsmead’s Half-Year Reality Check

Let’s cut straight to it: Baronsmead Second Venture Trust (BSVT) just reported a 7.1% drop in net asset value (NAV) per share for the six months to March 2025. That’s not a typo, and it’s certainly not business-as-usual for this stalwart of the VCT scene. The NAV slid from 55.2p to 51.3p, before ticking up to 54.1p by end-May. What’s behind the stumble? Buckle up – we’ve got political drama, market tremors, and a classic tale of public vs private equity resilience.

The Raw Numbers: More Than Just a NAV Dip

First, the headline stats:

  • NAV Per Share: 51.3p (down from 55.2p at Sept 2024 end)
  • Total NAV Return Since Launch (2001): 314.3p per £1 invested
  • Funds Raised: £13.8mn (period) + £1.2mn (post-period)
  • New Investments: £3.8mn (2 new unquoted, 9 follow-ons)
  • Interim Dividend: 1.75p/share (declared for Sept 2025 payment)

The real story? That 7.1% drop wasn’t random noise. It was a tale of two portfolios…

Public vs Private: The Volatility Tug-of-War

Chair Sarah Fromson didn’t mince words: the “period of domestic and global political uncertainty” post-November 2024 (yes, that US election) hammered sentiment. But here’s where BSVT’s hybrid structure proved its mettle:

The Unquoted Portfolio (28% of NAV)

Flat as a pancake. Zero change in value. Why? Sheer diversification. 35% of holdings gained value (notably CitySwift and Panthera Biopartners), 35% held steady, and 30% dipped (Orri and Huma Therapeutics struggled with “extending sales cycles” – govt spending sectors like health felt the pinch). This is private equity’s superpower: insulation from daily market hysterics.

The AIM & Collective Funds (64% of NAV)

Ouch. Direct AIM holdings plunged 11.6% (vs AIM index -7.1%). The WS Gresham House funds took hits too: UK Micro Cap (-3.5%), Smaller Companies (-7.5%), Multi Cap Income (-11.5%). Blame? “National insurance and minimum wage increases” squeezing UK small-caps, despite >80% of portfolio companies meeting/exceeding expectations. Brutal.

Silver lining: Post-March, AIM holdings rebounded +4.8% in April (vs AIM +1.5%) and +5.3% in May. Volatility cuts both ways.

Deal Flow: Planting Seeds in a Storm

While markets wobbled, BSVT kept investing – strategically:

  • New Unquoted: Mobility Mojo (disability access tech) & Much Better Adventures (bespoke travel)
  • Post-Period Adds: Penfold Tech, Nu Quantum, Spinners (£2.8mn total)
  • Follow-Ons: £2.3mn into 9 existing bets (including SecureCloud+ and Revlifter)

This isn’t reckless optimism. It’s the VCT playbook: deploy during downturns to capture value. As Fromson notes, this environment offers “high quality investments… at good prices.”

Realisation Realities: Cashing Chips Carefully

Exits were muted but telling:

  • Partial AIM Sales: Cerillion (25.7x return!) and SEEEN generated £0.3mn
  • Write-Offs: Crossword Cybersecurity (administration)
  • Unquoted: No realisations. Patience prevails.

Translation: Managers harvested gains where possible but avoided fire sales. That Cerillion return? A reminder why we stomach the volatility.

Shareholder Pulse: New Blood & Dividend Discipline

Despite the NAV dip, investor appetite held firm:

  • 526 new shareholders joined; 508 existing investors topped up
  • £13.8mn raised (period); £1.2mn since
  • Dividend policy remains anchored: targeting 7% yield on opening NAV (though “not a guarantee”)

The Board’s buyback policy (capping discounts at 5%) signals confidence – and liquidity matters in choppy markets.

Storm Clouds & Silver Linings: The Outlook

Fromson’s crystal ball is refreshingly candid:

  • Headwinds: US/UK trade tariffs, recession risks, “materially damaged” confidence, subdued exit markets
  • Tailwinds: Hybrid portfolio diversification, “sectors with long-term growth potential”, opportunistic pricing, elevated UK takeover activity (AIM exit upside)

Her verdict? “We remain committed to investing through the economic cycle.” Translation: Volatility isn’t an exit signal – it’s an entry point for disciplined VCTs.

The Takeaway: Grit Over Glitter

BSVT’s half-year reads like a masterclass in VCT reality: NAVs wobble, small-caps suffer whiplash, but well-structured portfolios weather storms. The 7.1% dip stings, but look deeper:

  • Unquoted holdings held the line
  • New capital flowed in (£15mn+ tax year to date)
  • Deal flow didn’t freeze
  • Dividends stayed on track

This isn’t a panic signal – it’s a reminder that VCT investing rewards marathon runners, not sprinters. As the trust navigates Labour’s Autumn Budget and Trump-era trade wars, that hybrid portfolio isn’t just diversification… it’s armour.

Disclosure: This is commentary, not advice. Always dig into the full RNS before any investment decision.

Disclaimer: This Blog is provided for general information about investments. It does not constitute investment advice. Information is taken from publicly available sources and any comment is that of the author who does not take any third party comment in the publication.
Last Updated

June 11, 2025

Category
Views
20
Likes
0

You might also enjoy 🔍

Minimalist digital graphic with a yellow-orange background, featuring 'Investing' in bold white letters at the centre and the 'Joshua Thompson' logo below.
Author picture
This article covers information on CT UK High Income Trust PLC.

Comments 💭

Leave a Comment 💬

No links or spam, all comments are checked.

First Name *
Surname
Comment *
No links or spam - will be automatically not approved.

Got an article to share?